Beausoleil, ClaireThébault, AnneCabaton, Nicolas JErmler, SibylleFromenty, BernardGaroche, ClémentineGriffin, Julian LHoffmann, SebastianKamstra, Jorke HKubickova, BarbaraLenters, VirissaKos, Vesna MunicPoupin, NathalieRemy, SylvieSapounidou, MariaZalko, DanielLegler, JulietteJacobs, Miriam NRousselle, ChristopheAndersson, Patrik2024-08-132024-08-132024-08-01Beausoleil, C, Thébault, A, Cabaton, N J, Ermler, S, Fromenty, B, Garoche, C, Griffin, J L, Hoffmann, S, Kamstra, J H, Kubickova, B, Lenters, V, Kos, V M, Poupin, N, Remy, S, Sapounidou, M, Zalko, D, Legler, J, Jacobs, M N, Rousselle, C & Andersson, P 2024, 'Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approach', Toxicology and Applied Pharmacology, vol. 489, 116995. https://doi.org/10.1016/j.taap.2024.1169950041-008XSCOPUS: 85196255433ORCID: /0000-0003-1336-7744/work/165792876https://hdl.handle.net/2164/24026All partners acknowledge the contribution of their institutes for additional financial support. We would also like to acknowledge the scientific contributions from François Pouzaud, Sakina Mhaouty-Kodja and René Habert for the development of the EKE methodology within the frame of the Anses ED Expert group. Contributions from additional members of the GOLIATH consortium: Pierre-Etienne Toulemonde and Romane Multon from Anses are also acknowledged.169978143engSDG 3 - Good Health and Well-beingMetabolism-disrupting chemicalsTriphenyl phosphate (TPP)ObesityPPARγWeight of evidenceElicitationQH301 BiologySupplementary Datahttps://ars.els-cdn.com/content/image/1-s2.0-S0041008X24001935-mmc1.docxhttps://ars.els-cdn.com/content/image/1-s2.0-S0041008X24001935-mmc2.xlsxQH301Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approachJournal article10.1016/j.taap.2024.116995https://www.sciencedirect.com/science/article/pii/S0041008X24001935?via%3Dihub489